Wikidata

(Q43594172)

English

Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results

scientific article

In more languages

Statements

title
Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11331325
retrieved
25 November 2017
author name string
D Breneman
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
11331325
retrieved
25 November 2017
A G Martin
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
11331325
retrieved
25 November 2017
P Myskowski
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
11331325
retrieved
25 November 2017
C Crowley
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
11331325
retrieved
25 November 2017
R C Yocum
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
11331325
retrieved
25 November 2017
Bexarotene Worldwide Study Group
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
11331325
retrieved
25 November 2017
page(s)
2456-2471
1 reference
stated in
Europe PubMed Central
PubMed ID
11331325
retrieved
25 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43594172&oldid=2101764384"